Cargando…

Changing clinical care cascade of patients with chronic hepatitis B in Beijing, China

BACKGROUND: High uptake of hepatitis B virus (HBV) tests and antiviral therapy are required to improve the clinical outcomes of patients with chronic hepatitis B (CHB) at the population level. In the current study, we used the Basic Medical Care Insurance for Employees (BMCIE) to investigate the cha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Min, Zhao, Lianhui, Zhou, Jialing, Sun, Yameng, Wu, Xiaoning, Ou, Xiaojuan, You, Hong, Kong, Yuanyuan, Jia, Jidong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406027/ https://www.ncbi.nlm.nih.gov/pubmed/34590058 http://dx.doi.org/10.1016/j.lanwpc.2021.100249

Ejemplares similares

A Meta-Analysis of the Efficacy of Interferon Monotherapy or Combined with Different Nucleos(t)ide Analogues for Chronic Hepatitis B
por: Zhou, Jialing, et al.
Publicado: (2016)

Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in chronic hepatitis B patients
por: Wu, Xiaoning, et al.
Publicado: (2023)

Noninvasive Evaluation of Liver Fibrosis Reverse Using Artificial Neural Network Model for Chronic Hepatitis B Patients
por: Wei, Wei, et al.
Publicado: (2019)

Control of Chronic Hepatitis B in China: Perspective of Diagnosis and Treatment
por: Wang, Yu, et al.
Publicado: (2020)

Impact of National Centralized Drug Procurement Policy on Antiviral Utilization and Expenditure for Hepatitis B in China
por: Zhao, Xinyu, et al.
Publicado: (2022)

Entecavir monotherapy versus de novo combination of lamivudine and adefovir for compensated hepatitis B virus-related cirrhosis: a real-world prospective multicenter cohort study
por: Wu, Xiaoning, et al.
Publicado: (2019)

Effective viral suppression is necessary to reduce hepatocellular carcinoma development in cirrhotic patients with chronic hepatitis B: Results of a 10-year follow up
por: Zhang, Wei, et al.
Publicado: (2017)

The Impact of the Definitions of Clinical Phases on the Profiles of Grey-Zone Patients with Chronic Hepatitis B Virus Infection
por: Xu, Xiaoqian, et al.
Publicado: (2023)

SHG/TPEF-based image technology improves liver fibrosis assessment of minimally sized needle biopsies
por: Wang, Bingqiong, et al.
Publicado: (2019)

Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022)
por: You, Hong, et al.
Publicado: (2023)

Quantitative assessment of liver fibrosis (qFibrosis) reveals precise outcomes in Ishak “stable” patients on anti-HBV therapy
por: Sun, Yameng, et al.
Publicado: (2018)

Advances in the diagnosis and treatment of viral hepatitis B and C in China
por: Jia, Jidong
Publicado: (2022)

Validation of Ten Noninvasive Diagnostic Models for Prediction of Liver Fibrosis in Patients with Chronic Hepatitis B
por: Cheng, Jieyao, et al.
Publicado: (2015)

Female gender lost protective effect against disease progression in elderly patients with chronic hepatitis B
por: You, Hong, et al.
Publicado: (2016)

A Better Antiviral Efficacy Found in Nucleos(t)ide Analog (NA) Combinations with Interferon Therapy than NA Monotherapy for HBeAg Positive Chronic Hepatitis B: A Meta-Analysis
por: Wei, Wei, et al.
Publicado: (2015)

Meta-Analysis of Antinuclear Antibodies in the Diagnosis of Antimitochondrial Antibody-Negative Primary Biliary Cholangitis
por: Zhang, Qian, et al.
Publicado: (2019)

Adenoviruses Associated with Acute Diarrhea in Children in Beijing, China
por: Liu, Liying, et al.
Publicado: (2014)

Changing trends of hospitalisation of liver cirrhosis in Beijing, China
por: Bao, Xiao-Yuan, et al.
Publicado: (2015)

Prevalence and Factors Associated with Hepatitis B Immunization and Infection among Men Who Have Sex with Men in Beijing, China
por: Wang, Chao, et al.
Publicado: (2012)

Impact of a New Reimbursement Program on Hepatitis B Antiviral Medication Cost and Utilization in Beijing, China
por: Qiu, Qian, et al.
Publicado: (2014)

Costs and health impact of delayed implementation of a national hepatitis B treatment program in China
por: Toy, Mehlika, et al.
Publicado: (2022)

Rarity of rpoB Mutations Outside the Rifampicin Resistance-Determining Region of Mycobacterium tuberculosis Isolates from Patients Responding Poorly to First-Line Tuberculosis Regimens in Beijing, China: A Retrospective Study
por: Guo, Jidong, et al.
Publicado: (2021)

Cost-utility analysis of newborn hepatitis B immunization in Beijing
por: Guo, Yiwei, et al.
Publicado: (2020)

Spatiotemporal patterns and risk factors concerning hepatitis B virus infections in the Beijing–Tianjin–Hebei area of China
por: Xu, C. D., et al.
Publicado: (2019)

Meeting report: Second Hydrogen Molecule Biomedical Symposium in Beijing, China
por: Chen, Ou-yang, et al.
Publicado: (2016)

Beijing, capital de China.
Publicado: (1982)

Cascade of care for children and adolescents with chronic hepatitis C
por: Rogers, Michael Evan, et al.
Publicado: (2021)

Cost-effectiveness of expanded antiviral treatment for chronic hepatitis B virus infection in China: an economic evaluation
por: Zhang, Sihui, et al.
Publicado: (2023)

A recurrent ABCC2 p.G693R mutation resulting in loss of function of MRP2 and hyperbilirubinemia in Dubin-Johnson syndrome in China
por: Wu, Lina, et al.
Publicado: (2020)

Investigation on Mycobacterium tuberculosis Diversity in China and the Origin of the Beijing Clade
por: Wan, Kanglin, et al.
Publicado: (2011)

Patient safety culture in China: a case study in an outpatient setting in Beijing
por: Liu, Chaojie, et al.
Publicado: (2014)

The Impact of Greenspace on Thermal Comfort in a Residential Quarter of Beijing, China
por: Wu, Zhifeng, et al.
Publicado: (2016)

Antiviral therapy for chronic hepatitis B in China
por: Zheng, Xin, et al.
Publicado: (2014)

Risk factors and clinical phenotypes of Beijing genotype strains in tuberculosis patients in China
por: Pang, Yu, et al.
Publicado: (2012)

Exploration of a new hepatitis a surveillance system in Beijing, China: based on molecular epidemiology
por: Wang, Huai, et al.
Publicado: (2022)

Inhibitory effects of HNF4α on migration/maltransformation of hepatic progenitors: HNF4α-overexpressing hepatic progenitors for liver repopulation
por: Wang, Ping, et al.
Publicado: (2017)

mcr-1 in Enterobacteriaceae from Companion Animals, Beijing, China, 2012–2016
por: Lei, Lei, et al.
Publicado: (2017)

Spatial-temporal detection of risk factors for bacillary dysentery in Beijing, Tianjin and Hebei, China
por: Xu, Chengdong, et al.
Publicado: (2017)

Factors Associated with Myopia in School Children in China: The Beijing Childhood Eye Study
por: You, Qi Sheng, et al.
Publicado: (2012)

Spatiotemporal heterogeneity of land subsidence in Beijing
por: Duan, Guangyao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2c7flb4hblrs8ltdvjfoqjq37s